Skip to main content

Mérieux Développement works alongside entrepreneurs and companies whose products and services can bring genuine advances to the health of patients and consumers worldwide, offering them access to its industry expertise and global network. Mérieux Développement is an affiliate of Institut Mérieux.

Sienna Capital & Mérieux Développement

In 2014, Sienna Capital committed an amount of EUR 75 million dedicated to both funds managed by Mérieux Développement: Mérieux Participations I and Mérieux Participations II. Sienna Capital benefits from certain favourable financial terms for its support of Mérieux Participations II.

Financial year 2015

In 2015, Mérieux Participations has completed incremental investments in existing portfolio companies. Mérieux Participations II has invested in two new companies: Ninox Medical and Origene Technologies. Furthermore, the team of Mérieux Développement has increased and two new offices were opened (in California and London).